Skip to content
ADDRESS-2 type 1 diabetes

ADDRESS-2 type 1 diabetes

Supporting type 1 diabetes research

Menu

  • Home
  • For People Living With Diabetes
    • Taking Part in Research
      • Impact
      • Through ADDRESS-2
      • Current Opportunities
      • Other Ways to Get Involved
    • Joining ADDRESS-2
      • How to and Next Steps
      • ADDRESS-2 Locations
      • Privacy and Data Security
  • For Researchers
    • How We Can Help
    • Samples Available
    • Data Available
    • Reference Documents
  • Further Information
    • Research Studies Previously Supported
    • More About Us
    • Contact Us
    • Publications from ADDRESS-2

A potential vaccine for type 1 diabetes: the MultiPepT1De trial

The latest study we are supporting is investigating a potential vaccine for type 1 diabetes. Find out about the MultiPepTide trial from the team running the trial, and from Diabetes UK.

Read about other studies we are supporting.

multipept1de-logo

liu-vaccine

A potential vaccine for type 1 diabetes: the MultiPepT1De trial
Tagged on: News
address-2 January 8, 2016December 2, 2016 Research study
  • Trial of a new drug aiming to preserve beta cells →

Share this content

Facebooktwitter

Follow Us

Facebooktwitter

Other Links

Privacy notices

Accessibility statement

Contact us

Email:
address2@imperial.ac.uk

Phone:
0207 594 1316
0207 594 5960

Postal address

Diabetes, Endocrinology and Metabolism
Imperial College London
G3, Medical School Building
Norfolk Place
London, W2 1PG

Copyright © 2025 ADDRESS-2 type 1 diabetes. All rights reserved. Theme Spacious by ThemeGrill. Powered by: WordPress.